Hi,

I'm on the FDA e-mail list and received info about the following 2 new drugs which I thought I would pass along:

FDA announced approval today, August 2, 2004, of two fixed-dose combination (FDC) antiretroviral drug products for use with other antiretroviral agents for the treatment of HIV-1 infection. The FDCs are GlaxoSmithKline's EPZICOM(tm) (abacavir/lamivudine) and Gilead Sciences, Inc.'s TRUVADA(tm) (tenofovir disoproxil/emtricitabine)

These FDC approvals are important because they provide simplified dosing regimens - one pill, once daily, for the component of multi-drug therapy represented by these FDCs.

TRUVADA(tm) (tenofovir disoproxil/emtricitabine) - Gilead Sciences, Inc.

* TRUVADA is a fixed-dose combination (FDC) of the antiretroviral drugs tenofovir disoproxil fumarate 300 mg (TDF) and emtricitabine 200 mg (FTC), both of which are approved individually under the brand names of VIREAD(tm) (tenofovir disoproxil fumarate) and EMTRIVA(tm) (emtricitabine).
* The approval of TRUVADA is based on bioequivalence studies demonstrating similar pharmacokinetic parameters of the combination product and the individual products, safety and efficacy data that exist for both components individually, and efficacy results from studies using the combination of TDF and lamivudine (3TC), [lamivudine is an approved product with many similarities to FTC] are being extrapolated to support the use of the TDF/FTC combination.
* TRUVADA should be considered as an alternative to TDF and 3TC for treatment naïve patients who might benefit from a once-a-day regimen.

EPZICOM(tm) (abacavir/lamivudine) - GlaxoSmithKline

* EPZICOM is a fixed dose combination (FDC) of the antiretroviral drugs abacavir sulfate 600 mg and lamivudine 300 mg, both of which are approved individually under the brand names of ZIAGEN(tm) (abacavir sulfate) and EPIVIR(tm) (lamivudine).
* EPZICOM is being approved based on a large well-controlled clinical study which showed that abacavir dosed once daily had similar antiviral effect as abacavir dosed twice daily both in conjunction with lamivudine and efaviranz.

If you have a doc like mine who treats HIV patients, they'll be using them real soon!

Thank you, kkb, for posting that information. It seems that new drugs are always coming out to treat HIV patients.